Emulsion Type New Vehicle for Soft Gelatin Capsule Available for Preclinical and Clinical Trials. Stabilization of New Vehicle Containing Vitamin K2 with PEG 6000.
-
- AMEMIYA Tohru
- Research & Development Section, Kakegawa Factory, R. P. Scherer K. K
-
- MIZUNO Satoshi
- R & D Non-Clinical Group, ALLERGAN K. K
-
- YUASA Hiroaki
- Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Nagoya City University
-
- WATANABE Jun
- Department of Biopharmaceutics, Faculty of Pharmaceutical Sciences, Nagoya City University
この論文をさがす
抄録
A new vehicle for a soft gelatin capsule with the basic formulation of PEG 400: water: medium chain triglyceride: polyoxyethylene (20) cetylether = 77: 10: 10: 3 was modified by partially replacing PEG 400 with PEG 6000 and added with vitamin K2 as a model drug, and the effects of PEG 6000 on the stability of the vehicle and vitamin K2 were studied for a period of 8 weeks at 4°C, room temperature and 40°C. For the vehicle containing 0.2% vitamin K2 (a vitamin dose), temperature-dependent gel-sol transformation was prevented by replacing 2.0 or 3.0% of PEG 400 with PEG 6000, and the particle size distribution and appearance were maintained stable during 8 weeks of storage at each temperature tested. The vitamin K2 was also found to be stable during the storage. Also for the vehicle containing 5.0% vitamin K2 (a pharmacological dose), both of the vehicle and vitamin K2, were found stable during 8 weeks of storage at every temperature. These results suggest that PEG 6000 plays an important role in maintaining the stability of vitamin K2 and the vehicle, preventing coagulation of particles, and this vehicle system could be used for preclinical and clinical trials.
収録刊行物
-
- 薬物動態
-
薬物動態 14 (5), 392-398, 1999
日本薬物動態学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204670217728
-
- NII論文ID
- 10008199787
-
- NII書誌ID
- AN10144117
-
- ISSN
- 09161139
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可